Printer Friendly
The Free Library
14,757,337 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AstraZeneca Japan Launches 24/7 Drug Alert Service.


Tokyo Tokyo (tō`kēō), city (1990 pop. 8,163,573), capital of Japan and of Tokyo prefecture, E central Honshu, at the head of Tokyo Bay. , Japan, July July: see month.  4, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - AstraZeneca K.K. reinforced its Medical Information Center (MIC) drug alert service by offering the round-the-clock service beginning on July 1. With assistance from the Japan Poison poison, any agent that may produce chemically an injurious or deadly effect when introduced into the body in sufficient quantity. Some poisons can be deadly in minute quantities, others only if relatively large amounts are involved.  Information Center, the company will respond to inquiries from medical professionals 24 hours a day, 365 days a year.

The Company hopes the improved service will encourage the proper use of pharmaceutical products and improve customer satisfaction.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Jul 6, 2006
Words:80
Previous Article:Takara Bio, Okayama University Jointly Confirm That Angelica Utilis Promotes Bone Formation and Increases Bone Mass.
Next Article:Trans Genic Receives Japanese Patent on Cancer Diagnosis Method Using Urine Samples.



Related Articles
ON24 Video Investor Alert: New Generation Cancer Smart Drug to Launch Mid 2002.
ON24 Audio Investor Alert: AstraZeneca Oncology Dir.: Expect Two Drug Launches in 2002.
AstraZeneca fined $355 million as U.S. cracks down on medicare fraud.(Front Page)(AstraZeneca PLC)
Pricing prescription drugs.(Trends And Transitions)(Rx Outreach, Together Rx Access)
Shimadzu Releases Advanced Nanoparticle Analyzer.
A second cholesterol drug poses hazards, may spawn suits.
Abraxis completes AstraZeneca purchase.
Astrazeneca Receives Japan Approval for CFC-free Corticosteroid Inhaler for Paediatric Asthma.
Abraxis waiting for cancer treatment to cure its Wall Street woes.(Corporate Focus)
Chugai Pharmaceutical to Establish an Oncology Unit.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles